Sex-specific alteration to α2-antiplasmin incorporation in patients with type 2 diabetes

Published on Jan 1, 2020in Thrombosis Research3.266
· DOI :10.1016/j.thromres.2019.09.032
Agata Hanna Bryk3
Estimated H-index: 3
(Jagiellonian University Medical College),
Jakub Siudut5
Estimated H-index: 5
(Jagiellonian University Medical College)
+ 4 AuthorsAnetta Undas41
Estimated H-index: 41
(Jagiellonian University Medical College)
Abstract Background Type 2 diabetes mellitus (T2DM) is associated with hypofibrinolysis and increased factor XIII-mediated α2-antiplasmin incorporation into the fibrin clot. It is unclear whether there are sex-related differences in α2-antiplasmin incorporation in relation to impaired clot lysis in T2DM. Aim We investigated α2-antiplasmin incorporation into fibrin clots as a determinant of clot lysability in patients of both sexes with T2DM. Methods In a group of 113 T2DM patients, 54 (47.8%) of which were women, we investigated α2-antiplasmin incorporation using an in-house sandwich enzyme-linked immunoassay and plasma clot lysis by turbidimetry, along with fibrinogen and thrombin generation using calibrated automated thrombogram and factor XIII activity. Results Female patients had 15.2% greater α2-antiplasmin incorporation into the fibrin clot with (p = 0.008) and slightly higher plasma α2-antiplasmin concentration (p = 0.005) along with 8.4% longer time to 50% lysis (Lys50MA, p = 0.012) compared with men. Female patients had enhanced thrombin generation represented by shorter lag phase (p = 0.042), shorter time to peak (p = 0.033), and higher endogenous thrombin potential (p = 0.003) compared with men, while factor XIII activity was comparable between sexes (p = 0.085). On multivariate regression, patient sex and glycated hemoglobin (HbA1c) level were the predictors of α2-antiplasmin incorporation in the entire patient group, while α2-antiplasmin incorporation was associated with Lys50MA, as were fibrinogen, male sex and body-mass index. Conclusions This study suggests that a more compromised fibrinolysis in diabetic women when compared with men could be in part mediated by increased α2-antiplasmin incorporation into the fibrin.
  • References (34)
  • Citations (1)
📖 Papers frequently viewed together
201415.27Diabetes Care
6 Authors (Anna Ågren, ..., Björn Wiman)
15 Citations
72 Citations
84 Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
#1Adrienn Teráz-Orosz (University of Debrecen)H-Index: 1
#2Andrea Csapó (University of Debrecen)H-Index: 1
Last. Éva Katona (University of Debrecen)H-Index: 16
view all 9 authors...
Abstract The ever-increasing research efforts to develop new antithrombotic therapies have led to the reassessment of the role of alpha-2-plasmin inhibitor (α2-PI) in pathological conditions. In particular, experimental stroke studies have suggested correlation between increased free α2-PI level and mortality. However there are only a small number of well-characterized and specific assays available for the measurements of free α2-PI. In plasma α2-PI undergoes both N- and/or C-terminal cleavages ...
1 CitationsSource
#1Agata Hanna Bryk (Jagiellonian University Medical College)H-Index: 3
#2Shannon M. Prior (UVM: University of Vermont)H-Index: 3
Last. Anetta Undas (Jan Kochanowski University)H-Index: 41
view all 8 authors...
Background Type 2 diabetes mellitus (T2DM) is associated with a hypercoagulable state and increased neutrophil extracellular traps formation (NETosis). We investigated predictors of NETosis and cell death markers in circulating blood and their association with a prothrombotic state in T2DM.
1 CitationsSource
#1Shirley Uitte de Willige (Erasmus University Medical Center)H-Index: 4
#2Joyce J.C.M. Malfliet (Erasmus University Medical Center)H-Index: 1
Last. Dingeman C. Rijken (Erasmus University Medical Center)H-Index: 24
view all 5 authors...
Abstract Introduction Circulating fibroblast activation protein (cFAP) cleaves alpha-2-antiplasmin (α2AP) N-terminally, converting native Met-α2AP into Asn-α2AP. Previous studies in purified model systems showed that Asn-α2AP is faster incorporated into a fibrin clot by activated factor XIII than Met-α2AP, making the fibrin clot more resistant to fibrinolysis. The objective was to investigate whether cFAP level in plasma associated with the amount of α2AP incorporation into fibrin in a new plasm...
1 CitationsSource
#1Arkadiusz Retwiński (Medical University of Łódź)H-Index: 1
#2Marcin Kosmalski (Medical University of Łódź)H-Index: 5
Last. Jarosław Drożdż (Medical University of Łódź)H-Index: 18
view all 10 authors...
Background: Metformin is one of the antihyperglycaemic drugs, reducing the risk of major cardiovascular events, including fatal ones. Although it is formally contraindicated in moderate and severe functional stages of heart failure (HF), it is commonly used in patients with concomitant type 2 diabetes mellitus (T2DM). Aim: We sought to evaluate the effect of metformin and T2DM on total mortality and hospitalisation rates in patients with HF. Methods: This retrospective analysis included 1030 adu...
2 CitationsSource
#1Marlien Pieters (NWU: North-West University)H-Index: 16
#2Helen Philippou (University of Leeds)H-Index: 27
Last. Nicola J. Mutch (Aberd.: University of Aberdeen)H-Index: 12
view all 6 authors...
11 CitationsSource
#1Wael Sumaya (University of Sheffield)H-Index: 4
#2Lars Wallentin (Uppsala University)H-Index: 124
Last. Robert F. Storey (University of Sheffield)H-Index: 63
view all 9 authors...
Aims: To determine whether fibrin clot properties are associated with clinical outcomes following acute coronary syndrome (ACS). Methods and results: Plasma samples were collected at hospital discharge from 4354 ACS patients randomized to clopidogrel or ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trial. A validated turbidimetric assay was employed to study plasma clot lysis time and maximum turbidity (a measure of clot density). One-year rates of cardiovascular (CV) death,...
27 CitationsSource
24 CitationsSource
#1Katherine J. Kearney (University of Leeds)H-Index: 2
#2Darren C. Tomlinson (University of Leeds)H-Index: 23
Last. Ramzi Ajjan (University of Leeds)H-Index: 33
view all 4 authors...
An enhanced thrombotic environment and premature atherosclerosis are key factors for the increased cardiovascular risk in diabetes. The occlusive vascular thrombus, formed secondary to interactions between platelets and coagulation proteins, is composed of a skeleton of fibrin fibres with cellular elements embedded in this network. Diabetes is characterised by quantitative and qualitative changes in coagulation proteins, which collectively increase resistance to fibrinolysis, consequently augmen...
12 CitationsSource
#1Dingeman C. Rijken (Erasmus University Medical Center)H-Index: 24
#2Shiraazkhan Abdul (Erasmus University Medical Center)H-Index: 2
Last. S. Uitte De Willige (Erasmus University Medical Center)H-Index: 10
view all 5 authors...
textabstractEssentials Factor XIIIa inhibits fibrinolysis by forming fibrin-fibrin and fibrin-inhibitor cross-links. Conflicting studies about magnitude and mechanisms of inhibition have been reported. Factor XIIIa most strongly inhibits lysis of mechanically compacted or retracted plasma clots. Cross-links of α2-antiplasmin to fibrin prevent the inhibitor from being expelled from the clot. Summary: Background Although insights into the underlying mechanisms of the effect of factor XIII on fibri...
15 CitationsSource
#1Shiraazkhan Abdul (Erasmus University Medical Center)H-Index: 2
#2Frank W.G. Leebeek (Erasmus University Medical Center)H-Index: 46
Last. Shirley Uitte de Willige (Erasmus University Medical Center)H-Index: 4
view all 4 authors...
Human α2-antiplasmin (α2AP, also called α2-plasmin inhibitor) is the main physiological inhibitor of the fibrinolytic enzyme plasmin. α2AP inhibits plasmin on the fibrin clot or in the circulation by forming plasmin-antiplasmin complexes. Severely reduced α2AP levels in hereditary α2AP deficiency may lead to bleeding symptoms, whereas increased α2AP levels have been associated with increased thrombotic risk. α2AP is a very heterogeneous protein. In the circulation, α2AP undergoes both amino term...
20 CitationsSource
Cited By1
Diabetes (both type-1 and type-2) affects millions of individuals worldwide. A major cause of death for individuals with diabetes is cardiovascular diseases, in part since both types of diabetes lead to physiological changes that affect haemostasis. Those changes include altered concentrations of coagulatory proteins, hyper-activation of platelets, changes in metal ion homeostasis, alterations in lipid metabolism (leading to lipotoxicity in the heart and atherosclerosis), the presence of pro-coa...